Cargando…
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists
Gleason score 7 prostate cancer with a higher proportion of pattern 4 (G4) has been linked to genomic heterogeneity and poorer patient outcome. The current assessment of G4 proportion uses estimation by a pathologist, with a higher proportion of G4 more likely to trigger additional imaging and treat...
Autores principales: | Carmona Echeverria, Lina Maria, Haider, Aiman, Freeman, Alex, Stopka-Farooqui, Urszula, Rosenfeld, Avi, Simpson, Benjamin S., Hu, Yipeng, Hawkes, David, Pye, Hayley, Heavey, Susan, Stavrinides, Vasilis, Norris, Joseph M., Bosaily, Ahmed El-Shater, Cardona Barrena, Cristina, Bott, Simon, Brown, Louise, Burns-Cox, Nick, Dudderidge, Tim, Henderson, Alastair, Hindley, Richard, Kaplan, Richard, Kirkham, Alex, Oldroyd, Robert, Ghei, Maneesh, Persad, Raj, Punwani, Shonit, Rosario, Derek, Shergill, Iqbal, Winkler, Mathias, Ahmed, Hashim U., Emberton, Mark, Whitaker, Hayley C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561724/ https://www.ncbi.nlm.nih.gov/pubmed/33057024 http://dx.doi.org/10.1038/s41598-020-73524-z |
Ejemplares similares
-
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort
por: Norris, Joseph M., et al.
Publicado: (2020) -
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial
por: Stavrinides, Vasilis, et al.
Publicado: (2023) -
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2021) -
HIV and the histopathologist
por: Nel, Carolina E.
Publicado: (2017) -
Defining the level of evidence for technology adoption in the localized prostate cancer pathway
por: Valerio, Massimo, et al.
Publicado: (2014)